| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-13 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-12 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-11 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |